DE69329031D1 - Das dorsalgewebe beeinflussender faktor - Google Patents

Das dorsalgewebe beeinflussender faktor

Info

Publication number
DE69329031D1
DE69329031D1 DE69329031T DE69329031T DE69329031D1 DE 69329031 D1 DE69329031 D1 DE 69329031D1 DE 69329031 T DE69329031 T DE 69329031T DE 69329031 T DE69329031 T DE 69329031T DE 69329031 D1 DE69329031 D1 DE 69329031D1
Authority
DE
Germany
Prior art keywords
noggin
seq
dorsal
influencing factor
dorsal tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69329031T
Other languages
English (en)
Other versions
DE69329031T2 (de
Inventor
M Harland
C Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of DE69329031D1 publication Critical patent/DE69329031D1/de
Application granted granted Critical
Publication of DE69329031T2 publication Critical patent/DE69329031T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69329031T 1992-09-03 1993-09-02 Das dorsalgewebe beeinflussender faktor Expired - Lifetime DE69329031T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93995492A 1992-09-03 1992-09-03
PCT/US1993/008325 WO1994005800A1 (en) 1992-09-03 1993-09-02 Dorsal tissue affecting factor and compositions

Publications (2)

Publication Number Publication Date
DE69329031D1 true DE69329031D1 (de) 2000-08-17
DE69329031T2 DE69329031T2 (de) 2001-03-22

Family

ID=25473995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329031T Expired - Lifetime DE69329031T2 (de) 1992-09-03 1993-09-02 Das dorsalgewebe beeinflussender faktor

Country Status (11)

Country Link
US (1) US5670481A (de)
EP (1) EP0662146B1 (de)
AT (1) ATE194658T1 (de)
AU (1) AU5125693A (de)
DE (1) DE69329031T2 (de)
DK (1) DK0662146T3 (de)
ES (1) ES2149823T3 (de)
GR (1) GR3034554T3 (de)
PT (1) PT662146E (de)
WO (1) WO1994005800A1 (de)
ZA (1) ZA936478B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679783A (en) * 1994-11-22 1997-10-21 The Regents Of The University Of California DNA encoding a tissue differentiation affecting factor
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors
AU6267098A (en) * 1997-02-05 1998-08-25 Regents Of The University Of California, The Morphogenic proteins
JP4357003B2 (ja) * 1997-02-19 2009-11-04 リジェネロン ファーマシューティカルズ，インコーポレイテッド 形態形成タンパク質
US6075007A (en) * 1997-07-17 2000-06-13 Regeneron Pharmaceuticals, Inc. Modified noggin polypeptide and compositions
WO1999061044A1 (en) * 1998-05-28 1999-12-02 The Board Of Trustees Of The University Of Arkansas Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
US6087168A (en) 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
EP1615596B1 (de) 2003-04-11 2016-11-02 Etex Corporation Osteoinduktives knochenmaterial
WO2005025595A2 (en) 2003-09-12 2005-03-24 Wyeth Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2007028212A1 (en) * 2005-09-08 2007-03-15 Apollo Life Sciences Limited Noggin and chimeric molecules thereof
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
WO2007092622A2 (en) 2006-02-09 2007-08-16 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
CA2656278C (en) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions and methods for treating rotator cuff injuries
US20090061002A1 (en) 2007-09-05 2009-03-05 Venbrocks Rudolf A Calcium phospate based delivery of growth and differentiation factors to compromised bone
NZ602861A (en) 2008-09-09 2014-03-28 Biomimetic Therapeutics Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
CA2790403C (en) 2010-02-22 2019-08-27 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
US10034945B2 (en) 2012-07-13 2018-07-31 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
EP3368016B1 (de) 2015-10-26 2020-10-21 President and Fellows of Harvard College Reduzierte und oxidierte polysaccharide und verfahren zur verwendung davon
US10961305B2 (en) 2016-12-21 2021-03-30 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
AT521641B1 (de) * 2018-09-12 2020-07-15 Fianostics Gmbh Verfahren zur Diagnose von Lebererkrankungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933294A (en) * 1984-01-30 1990-06-12 Icrf Patents Limited Method of detecting truncated epidermal growth factor receptors
WO1986006096A1 (en) * 1985-04-11 1986-10-23 The Children's Medical Center Corporation Von willebrand factor
US5030576A (en) * 1986-04-30 1991-07-09 Genentech, Inc. Receptors for efficient determination of ligands and their antagonists or agonists
US4857637A (en) * 1986-05-07 1989-08-15 Genentech, Inc. Methods and compositions for immunologically modulating growth hormone receptor activity
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
US5149637A (en) * 1987-04-06 1992-09-22 Scripps Clinic & Research Foundation Recombinant Factor VIIIC fragments
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
GR1000980B (el) * 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
DK0550665T3 (da) * 1990-09-25 1996-12-02 Genentech Inc Ny neurotrofisk faktor

Also Published As

Publication number Publication date
EP0662146A4 (de) 1996-03-13
ATE194658T1 (de) 2000-07-15
WO1994005800A1 (en) 1994-03-17
ZA936478B (en) 1994-09-30
AU5125693A (en) 1994-03-29
PT662146E (pt) 2000-12-29
GR3034554T3 (en) 2001-01-31
EP0662146B1 (de) 2000-07-12
EP0662146A1 (de) 1995-07-12
DK0662146T3 (da) 2000-11-13
ES2149823T3 (es) 2000-11-16
DE69329031T2 (de) 2001-03-22
US5670481A (en) 1997-09-23

Similar Documents

Publication Publication Date Title
DE69329031T2 (de) Das dorsalgewebe beeinflussender faktor
IL97758A0 (en) Epithelins:cysteine-rich growth modulating proteins
MX9602259A (es) Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion.
JPH0395199A (ja) グリオーマ由来増殖因子の精製及び特徴
YU71395A (sh) Acilovani analozi insulina
DK0728146T3 (da) Conotoxinpeptider
MY123371A (en) Protein for blocking platelet adhesion
DE10075019I2 (de) Neue Proteine mit TNF-Hemmender Wirkung und ihre Herstellung.
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
DE69942035D1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
CA2104678A1 (en) Protein-induced morphogenesis
EP0307513A3 (de) Hydrophobe, mit Oberflächenaktivität assoziierte Proteine aus der Lunge
SUNADA et al. Mechanism of collagen degradation by collagenase: a transition process of the collagen molecule from collagenase-substrate to gelatinase-substrate
EP0241136A3 (de) Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
DK0493581T3 (da) Rekombinant gen der koder for et protein med endochitinaseaktivitet
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
US5459250A (en) Truncated mammalian growth factor DNA sequence
WO2001080811A3 (en) Mmp-2 propeptide for use as antiangiogenic or antitumor agent
Shoyah et al. Epitheli
HK1017817A1 (en) Novel cytokine
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
NO923861L (no) Epiteliner: nye vekstregulerende proteiner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition